MedTrace Logo

SARS-CoV-2, TESTOSTERONE AND MALE FRAGILITY

NCT06177002 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2023-12-20

No results posted yet for this study

Summary

The hormonal environment (steroid, primarily) could have a very relevant pathophysiological role in association with SARS-CoV-2. That is, testosterone could play a relevant role in leaving male subjects more exposed to infection and more prone to developing severe complications following COVID-19 infection.

Conditions

  • COVID-19
  • Testosterone Deficiency
  • Infertility, Male

Interventions

DIAGNOSTIC_TEST

Collection of biological data

Biological sample will be collected from the COVID19 patients and from healthy donors

Sponsors & Collaborators

  • IRCCS San Raffaele

    lead OTHER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-19
Primary Completion
2025-05-18
Completion
2025-05-18

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06177002 on ClinicalTrials.gov